Cinctive Capital Management’s Legend Biotech LEGN Stock Holding History

Cinctive Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$522K	Sell	18,091 -51,495	-74%	-$1.39M	0.02%	357
2026 Q1	$1.26M	Buy	+69,586	New	+$1.33M	0.08%	240
2025 Q2	–	Sell	-18,825	Closed	-$639K	–	441
2025 Q1	$639K	Sell	18,825 -11,869	-39%	-$426K	0.05%	243
2024 Q4	$999K	Buy	+30,694	New	+$1.27M	0.05%	278
2022 Q3	–	Sell	-20,000	Closed	-$1.1M	–	544
2022 Q2	$1.1M	Buy	+20,000	New	+$845K	0.05%	389

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Cinctive Capital Management's LEGN Position: Q2 2026 in Review

Cinctive Capital Management reduced its Legend Biotech (LEGN) stake by 74% in Q2 2026, selling an estimated $1.39M and leaving 18,091 shares worth $522K. The position accounts for 0.02% of the portfolio, ranked #357.

Cinctive Capital Management first reported a position in LEGN in Q2 2022 and has held it in 5 quarters since. The position peaked at $1.26M in Q1 2026. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Cinctive Capital Management held 18,091 shares of Legend Biotech worth $522K as of Q2 2026.
Cinctive Capital Management sold 51,495 Legend Biotech shares in Q2 2026, an estimated $1.39M.
Legend Biotech made up 0.02% of Cinctive Capital Management's portfolio in Q2 2026, its #357 holding.
Cinctive Capital Management first reported a position in Legend Biotech in Q2 2022 and has held it in 5 quarters since.
Cinctive Capital Management's Legend Biotech position peaked at $1.26M in Q1 2026.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.